NO20084088L - Preparater og fremgangsmater for levering av aminofunksjonelle legemidler - Google Patents
Preparater og fremgangsmater for levering av aminofunksjonelle legemidlerInfo
- Publication number
- NO20084088L NO20084088L NO20084088A NO20084088A NO20084088L NO 20084088 L NO20084088 L NO 20084088L NO 20084088 A NO20084088 A NO 20084088A NO 20084088 A NO20084088 A NO 20084088A NO 20084088 L NO20084088 L NO 20084088L
- Authority
- NO
- Norway
- Prior art keywords
- polymer matrix
- methods
- polymer
- preparations
- delivery
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 2
- 239000003814 drug Substances 0.000 title 1
- 229940079593 drug Drugs 0.000 title 1
- 238000002360 preparation method Methods 0.000 title 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 title 1
- 229920000642 polymer Polymers 0.000 abstract 7
- 239000011159 matrix material Substances 0.000 abstract 5
- 229930000680 A04AD01 - Scopolamine Natural products 0.000 abstract 2
- STECJAGHUSJQJN-GAUPFVANSA-N Hyoscine Natural products C1([C@H](CO)C(=O)OC2C[C@@H]3N([C@H](C2)[C@@H]2[C@H]3O2)C)=CC=CC=C1 STECJAGHUSJQJN-GAUPFVANSA-N 0.000 abstract 2
- STECJAGHUSJQJN-UHFFFAOYSA-N N-Methyl-scopolamin Natural products C1C(C2C3O2)N(C)C3CC1OC(=O)C(CO)C1=CC=CC=C1 STECJAGHUSJQJN-UHFFFAOYSA-N 0.000 abstract 2
- STECJAGHUSJQJN-FWXGHANASA-N scopolamine Chemical compound C1([C@@H](CO)C(=O)O[C@H]2C[C@@H]3N([C@H](C2)[C@@H]2[C@H]3O2)C)=CC=CC=C1 STECJAGHUSJQJN-FWXGHANASA-N 0.000 abstract 2
- 229960002646 scopolamine Drugs 0.000 abstract 2
- XTXRWKRVRITETP-UHFFFAOYSA-N Vinyl acetate Chemical compound CC(=O)OC=C XTXRWKRVRITETP-UHFFFAOYSA-N 0.000 abstract 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N acrylic acid group Chemical group C(C=C)(=O)O NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 abstract 1
- 150000001412 amines Chemical class 0.000 abstract 1
- 230000035515 penetration Effects 0.000 abstract 1
- 229920005573 silicon-containing polymer Polymers 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
- A61K9/7061—Polyacrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7069—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained otherwise than by reactions only involving carbon to carbon unsaturated bonds, e.g. polysiloxane, polyesters, polyurethane, polyethylene oxide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Emergency Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Otolaryngology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Compositions Of Macromolecular Compounds (AREA)
Abstract
Det er beskrevet fleksible, endelige systemer for transdermal administrering av skopolamin som omfatter: (a) en polymermatriks som omfatter en polymerblanding som omfatter (i) en ikke-funksjonell akrylbasert polymer som utgjør minst 60 vekt% av tørrvekten av polymermatriksen, og (ii) en aminresistent kapslet silikonpolymer som utgjør ikke mer enn ca. 30 vekt% av tørrvekten av polymermatriksen; og (b) skopolamin solubilisert i polymermatriksen, hvori det fleksible, endelige system er hovedsakelig fritt for vinylacetat og polare komponenter. I noen utforminger omfatter polymermatriksen også en ikke-polar penetreringsforsterker. Fremgangsmåter til å fremstille og bruke slike fleksible, endelige systemer er også beskrevet.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US77725706P | 2006-02-27 | 2006-02-27 | |
PCT/US2007/004911 WO2007100757A2 (en) | 2006-02-27 | 2007-02-26 | Transdermal therapeutic system comprising scopolamine |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20084088L true NO20084088L (no) | 2008-11-19 |
Family
ID=38266708
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20084088A NO20084088L (no) | 2006-02-27 | 2008-09-25 | Preparater og fremgangsmater for levering av aminofunksjonelle legemidler |
Country Status (11)
Country | Link |
---|---|
US (1) | US8715723B2 (no) |
EP (1) | EP1998756A2 (no) |
JP (1) | JP2009528357A (no) |
CN (1) | CN101431988A (no) |
AU (1) | AU2007221117A1 (no) |
CA (1) | CA2643037C (no) |
MX (1) | MX2008010934A (no) |
NO (1) | NO20084088L (no) |
RU (1) | RU2008138595A (no) |
WO (1) | WO2007100757A2 (no) |
ZA (1) | ZA200807408B (no) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2011329066B2 (en) | 2010-11-15 | 2017-03-09 | The Ohio State University Research Foundation | Controlled release mucoadhesive systems |
US9717697B2 (en) | 2012-10-15 | 2017-08-01 | Noven Pharmaceuticals, Inc. | Compositions and methods for the transdermal delivery of methylphenidate |
WO2014106016A1 (en) | 2012-12-28 | 2014-07-03 | Noven Pharmaceuticals, Inc | Multi-polymer compositions for transdermal drug delivery |
US9314470B2 (en) | 2012-12-28 | 2016-04-19 | Noven Pharmaceuticals, Inc. | Transdermal drug delivery systems for levonorgestrel and ethinyl estradiol |
US11337936B2 (en) | 2013-03-14 | 2022-05-24 | Noven Pharmaceuticals, Inc. | Amphetamine transdermal compositions with acrylic block copolymer |
AR095259A1 (es) | 2013-03-15 | 2015-09-30 | Noven Pharma | Composiciones y métodos para la administración transdérmica de fármacos de amina terciaria |
AR095260A1 (es) | 2013-03-15 | 2015-09-30 | Noven Pharma | Composiciones de anfetaminas transdérmicas estables y métodos de fabricación |
ES2733812T3 (es) * | 2014-07-31 | 2019-12-03 | Noven Pharma | Polímeros acrílicos que contienen silicona para composiciones de administración transdérmica de fármacos |
JP6807848B2 (ja) | 2015-02-06 | 2021-01-06 | ノーヴェン ファーマシューティカルズ インコーポレイテッド | 経皮薬物送達のための感圧粘着剤 |
US10406116B2 (en) | 2015-02-06 | 2019-09-10 | Noven Pharmaceuticals, Inc. | Pressure-sensitive adhesives for transdermal drug delivery |
WO2018026759A1 (en) * | 2016-08-03 | 2018-02-08 | Noven Pharmaceuticals, Inc. | Pressure-sensitive adhesives for transdermal drug delivery |
WO2019002208A1 (en) * | 2017-06-26 | 2019-01-03 | Lts Lohmann Therapie-Systeme Ag | TRANSDERMAL THERAPEUTIC SYSTEM CONTAINING SCOPOLAMINE AND A SILICONE-TYPE ACRYLIC HYBRID POLYMER |
DE102018118507A1 (de) * | 2018-07-31 | 2020-02-06 | Lts Lohmann Therapie-Systeme Ag | Transdermales therapeutisches System zur Abgabe von Scopolamin ohne Membran |
CA3133952A1 (en) * | 2019-03-19 | 2020-09-24 | Nobelpharma Co., Ltd. | Pharmaceutical composition having excellent drug absorption into the living body and excellent chemical stability |
Family Cites Families (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3797494A (en) | 1969-04-01 | 1974-03-19 | Alza Corp | Bandage for the administration of drug by controlled metering through microporous materials |
US4031894A (en) | 1975-12-08 | 1977-06-28 | Alza Corporation | Bandage for transdermally administering scopolamine to prevent nausea |
US4814168A (en) | 1988-03-04 | 1989-03-21 | Noven Pharmaceuticals, Inc. | Transdermal multipolymer drug delivery system |
US5474783A (en) | 1988-03-04 | 1995-12-12 | Noven Pharmaceuticals, Inc. | Solubility parameter based drug delivery system and method for altering drug saturation concentration |
US5656286A (en) | 1988-03-04 | 1997-08-12 | Noven Pharmaceuticals, Inc. | Solubility parameter based drug delivery system and method for altering drug saturation concentration |
US4994267A (en) | 1988-03-04 | 1991-02-19 | Noven Pharmaceuticals, Inc. | Transdermal acrylic multipolymer drug delivery system |
ES2097145T3 (es) | 1990-03-28 | 1997-04-01 | Noven Pharma | Metodo y dispositivo para la liberacion de farmacos en la piel. |
US5714162A (en) | 1994-09-16 | 1998-02-03 | Lts Lohmann Therapie-Systeme Gmbh & Co. Kg | Scopolamine patch |
US6024974A (en) * | 1995-01-06 | 2000-02-15 | Noven Pharmaceuticals, Inc. | Composition and methods for transdermal delivery of acid labile drugs |
US5601839A (en) | 1995-04-26 | 1997-02-11 | Theratech, Inc. | Triacetin as a penetration enhancer for transdermal delivery of a basic drug |
US6316022B1 (en) | 1995-06-07 | 2001-11-13 | Noven Pharmaceuticals, Inc. | Transdermal compositions containing low molecular weight drugs which are liquid at room temperatures |
DE19738643C2 (de) | 1997-09-04 | 2001-10-04 | Lohmann Therapie Syst Lts | Transdermales therapeutisches System mit dem Wirkstoff Scopolaminbase und Verfahren zu seiner Herstellung |
US6210705B1 (en) * | 1997-12-15 | 2001-04-03 | Noven Pharmaceuticals, Nc. | Compositions and methods for treatment of attention deficit disorder and attention deficit/hyperactivity disorder with methylphenidate |
US20030170195A1 (en) | 2000-01-10 | 2003-09-11 | Noven Pharmaceuticals, Inc. | Compositions and methods for drug delivery |
AU5325000A (en) | 1999-06-05 | 2000-12-28 | David Houze | Solubility enhancement of drugs in transdermal drug delivery systems and methodsof use |
DE10033853A1 (de) * | 2000-07-12 | 2002-01-31 | Hexal Ag | Transdermales therapeutisches System mit hochdispersem Siliziumdioxid |
AU2001292781A1 (en) | 2000-09-19 | 2002-04-02 | National Starch And Chemical Investment Holding Corporation | Acryl adhesive useful in transdermal drug delivery systems |
US20060078602A1 (en) * | 2004-10-08 | 2006-04-13 | Noven Pharmaceuticals, Inc. | Device for transdermal administration of drugs including acrylic polymers |
JP4704764B2 (ja) * | 2005-02-03 | 2011-06-22 | 日東電工株式会社 | 爪貼付用粘着組成物および爪用貼付剤 |
-
2007
- 2007-02-26 RU RU2008138595/15A patent/RU2008138595A/ru not_active Application Discontinuation
- 2007-02-26 EP EP07751653A patent/EP1998756A2/en not_active Withdrawn
- 2007-02-26 CA CA2643037A patent/CA2643037C/en active Active
- 2007-02-26 CN CNA2007800152407A patent/CN101431988A/zh active Pending
- 2007-02-26 MX MX2008010934A patent/MX2008010934A/es not_active Application Discontinuation
- 2007-02-26 AU AU2007221117A patent/AU2007221117A1/en not_active Abandoned
- 2007-02-26 JP JP2008557323A patent/JP2009528357A/ja active Pending
- 2007-02-26 US US11/710,610 patent/US8715723B2/en active Active
- 2007-02-26 WO PCT/US2007/004911 patent/WO2007100757A2/en active Application Filing
-
2008
- 2008-01-01 ZA ZA200807408A patent/ZA200807408B/xx unknown
- 2008-09-25 NO NO20084088A patent/NO20084088L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
JP2009528357A (ja) | 2009-08-06 |
WO2007100757A3 (en) | 2007-10-18 |
EP1998756A2 (en) | 2008-12-10 |
CN101431988A (zh) | 2009-05-13 |
WO2007100757A2 (en) | 2007-09-07 |
CA2643037C (en) | 2014-08-05 |
MX2008010934A (es) | 2008-10-30 |
RU2008138595A (ru) | 2010-04-10 |
ZA200807408B (en) | 2009-09-30 |
AU2007221117A1 (en) | 2007-09-07 |
US8715723B2 (en) | 2014-05-06 |
CA2643037A1 (en) | 2007-09-07 |
US20070212410A1 (en) | 2007-09-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20084088L (no) | Preparater og fremgangsmater for levering av aminofunksjonelle legemidler | |
MY180698A (en) | Immunization protocol against the 4 dengue serotypes | |
TW200735770A (en) | Pesticide delivery system | |
DK1061900T3 (da) | Dermale præparater | |
MY169275A (en) | Method of immunization against the four serotypes of dengue | |
NO20056241L (no) | Nanopartikler av polyoksyetylenerte derivater | |
NO20090305L (no) | Cyklosporin formuleringer | |
AU743229C (en) | Transdermal therapeutic system containing pergolide | |
UA99659C2 (uk) | Мультивалентна вакцина з нативних везикул зовнішньої мембрани менінгококів, способи її застосування | |
NZ588883A (en) | Permeant delivery system and methods for use thereof | |
CY1111040T1 (el) | Διαχειριση εκκρεμων εντολων χορηγησης φαρμακευτικης αγωγης | |
EP2636416A3 (en) | Phase-separated block copolymer coatings for implantable medical devices | |
MX2009008309A (es) | Composiciones hinchables y metodos y dispositivos para controlarlas. | |
DK1940243T3 (da) | Kostfiberformulering og fremgangsmåde til indgivelse | |
MX2010008945A (es) | Sistema de administracion de drogas con efecto estabilizante. | |
NO20052894L (no) | 4-tetrazolyl-4-fenylpiperidin-derivater for behandling av smerte | |
RS52671B (en) | IMPROVED TESTOSTERON GEL AND USE PROCEDURE | |
ATE434639T1 (de) | Wässrige dispersionen von silikon-polyether- blockcopolymeren | |
WO2007103594A3 (en) | System and method for providing single sign-on functionality | |
WO2007035515A3 (en) | A method of intraepithelial and systemic exposure of therapeutic agents following vaginal and oral cavity administration | |
NO20062234L (no) | Transdemisk,farmasoytisk spray-formulering omfattende en VP/UA kopolymer og en ikke-vandig vehikkel | |
WO2011018800A3 (en) | In-situ gel forming solution for ocular drug delivery | |
NO20062594L (no) | Transdermal delivery system of hormones without penetration enhancers | |
NO20081035L (no) | Ikke-invasivt legemiddel-leveringssystem som anvender en fast sammensetning pa vevet i bakre segment av oyet | |
TN2010000008A1 (en) | Oral pharmaceutical solutions containing telbivudine |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |